Respiration Scan develops healthcare solutions for disease prediction and diagnostics. The company's technology non-invasively detects volatile organic compounds in human breath to detect, predict, and diagnose a variety of disease states. Its software is designed to continuously learn new disease states. Respiration Scan gives doctors the tools to diagnose patients sooner, decreasing the time to specific treatment and improving clinical and financial outcomes. The company's platform utilizes cheminformatics and machine learning to diagnose new disease states via a patented breath diagnostics platform. Its breath diagnostics tool detects pneumonia 48 hours earlier than current methods. The platform saves lives, improves clinical outcomes & reduces costs to healthcare systems.